TWO · Healthcare

TCM Biotech International Corp. (4169)

Biotechnology

TCM Biotech International Corp. (4169) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 4169

P/E ratio

18.00

TCM Biotech International Corp. (4169) — FAQ

What is 4169's P/E ratio?

The price-to-earnings (P/E) ratio for TCM Biotech International Corp. (4169) is 18.00 (data as of 2026-03-23).

Does TCM Biotech International Corp. pay a dividend?

Dividend yield is not available in the current snapshot for TCM Biotech International Corp. (4169). Check the MyAverix Finance app for the latest dividend data.

What sector is TCM Biotech International Corp. in?

TCM Biotech International Corp. (4169) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 4169 listed on?

4169 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)